Latin America market for anticoccidial drugs is estimated to grow from USD 85.72 Million in 2022 to USD 104.85 Million by 2027 at a CAGR of 4.11%. The ban on consumption of antibiotics as a source of animal feed and the upsurge in incidences of antibiotic resistance microbes has seen a reduced growth in the antibiotic market, nevertheless the rising incidence of coccidiosis over the preceding 50 years and its control on the overall cost to benefit ratio for the meat industry has furthered the anticoccidials drug market.
Coccidiosis infects a wide range of animals, such as cattle, poultry species, pigs and sheep which is responsible for the downfall in meat production. Further, an increase in consumer awareness for a healthy diet containing meat proteins is causing a demand for meat production. This has created a need for the adoption of antibiotics (Anticoccidial drugs) by farmers to meet the growing demand for meat production. Besides, less stringent regulations and increased expenditure on companion animals are also assistants in the growth of Latin America anticoccidial drugs market. Further, the trend of owning companion animals is causative to the growing usage of anticoccidials in developing regions.
The Latin America anticoccidial drugs market is classified based on various types of animals and by type of drugs. The animal segment is sub-categorized into poultry, swine, fish, cattle and companion animals. The companion animal segment is divided into dogs and cats. In addition to this, the market is segmented under antibiotic anticoccidials, Ionophore anticoccidials, and chemical derivative anticoccidials. Furthermore, on the basis of geography, the Latin America Market is analyzed under various regions namely, Argentina, Brazil, and Mexico.
The anticoccidial market is facing diverse challenges in form of microbial resistance build-up to antibiotics and stringent government regulations in developed nations, consequently forcing the major players to look for leniently regulated markets in the Latin American regions. These were the regions estimated to grow the most during the forecasted period. Some of the key players operating in the market are Bayer Health care, Zoetis, Elanco, Merial, Merck Animal Healthcare, Virbac, Ceva Santé Animale, Boehringer Ingelheim Animal Health, Novartis Animal Healthcare, and Smartvet Inc.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Analysis Design
2.3 Research Phases
2.3.1 Secondary Research
2.3.2 Primary Research
2.3.3 Econometric Modelling
2.3.4 Expert Validation
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Drug Type
5.1.1 Antibiotic anticoccidials
5.1.2 Ionophore anticoccidials
5.1.3 Chemical derivative anticoccidials
5.2 By Animal Type
5.2.1 Poultry
5.2.2 Swine
5.2.3 Fish
5.2.4 Cattle
5.2.5 Companion Animal
6. Geographical Analysis
6.1 Introduction
6.2 Brazil
6.3 Argentina
6.4 Mexico
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Bayer Health care
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Zoetis
8.3 Elanco
8.4 Merck Animal Healthcare
8.5 Virbac
8.6 Ceva Santé Animale
8.7 Boehringer Ingelheim Animal Health
8.8 Novartis Animal Healthcare
8.9 Smartvet Inc.
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.